Hepatocellular Pattern of Liver Injury with Normal Biliary Function
This pattern indicates hepatocellular injury (elevated ALT 138 U/L and AST 74 U/L) with a normal GGT, suggesting the liver damage is NOT due to cholestatic/biliary disease or alcohol-related liver disease.
Pattern Recognition
Your liver enzyme pattern shows:
- ALT elevated to ~3-4x upper limit of normal (assuming ULN ~35-40 U/L)
- AST elevated to ~2x upper limit of normal
- AST/ALT ratio of 0.54 (74/138), which is <1
- Normal GGT - this is the critical finding
What This Pattern Tells Us
The normal GGT essentially rules out several key diagnoses:
Most Likely NOT:
- Alcohol-related liver disease - In alcoholic hepatitis, the AST/ALT ratio is typically >2, often >3, and GGT is almost always elevated 1, 2. Your ratio of 0.54 with normal GGT makes alcohol highly unlikely as the primary cause.
- Cholestatic/biliary disease - Normal GGT confirms the elevated transaminases are not from bile duct obstruction or cholestasis 3
- Chronic alcohol use - GGT is elevated in 70-80% of chronic alcohol users; normal GGT has high negative predictive value 2
Most Likely Causes (in order of probability):
1. Non-Alcoholic Fatty Liver Disease (NAFLD/NASH)
- Most common cause of this pattern in developed countries 3
- Typically shows AST/ALT ratio <1 (yours is 0.54) 3
- ALT levels usually <250 U/L, rarely >300 U/L 4
- Associated with metabolic syndrome, obesity, diabetes, insulin resistance 3
2. Viral Hepatitis (B or C)
- Can present with mild-moderate transaminase elevation 3
- Hepatitis C can have normal or mildly elevated ALT 5
- Requires serologic testing to confirm/exclude
3. Drug-Induced Liver Injury
- Many medications cause hepatocellular pattern 3
- Review all medications, supplements, herbal products
4. Other Hepatocellular Causes
- Autoimmune hepatitis
- Hemochromatosis
- Wilson disease (less likely in adults)
- Alpha-1 antitrypsin deficiency 3
Recommended Workup Algorithm
Step 1: Clinical Assessment
- Measure BMI, waist circumference (metabolic syndrome markers)
- Quantify alcohol intake precisely (grams/week)
- Complete medication/supplement review
- Family history of liver disease 6
- Screen for diabetes risk factors
Step 2: Initial Laboratory Tests
- Hepatitis B surface antigen, Hepatitis C antibody
- Fasting glucose, HbA1c, lipid panel
- Iron studies (ferritin, transferrin saturation)
- Consider: ANA, anti-smooth muscle antibody (if autoimmune suspected)
Step 3: Imaging
- Abdominal ultrasound is first-line 3
- Assesses for steatosis (>33% sensitivity 85%, specificity 94%)
- Evaluates liver size, echotexture
- Rules out structural abnormalities
Step 4: Fibrosis Assessment (if NAFLD confirmed)
- Calculate APRI score: [(AST/ULN)/platelets] × 100
- Calculate FIB-4 score if age and platelet count available
- Consider elastography if available 7
Critical Clinical Pearls
The magnitude of enzyme elevation does NOT correlate with prognosis 5. A patient with ALT 138 U/L from NAFLD may have significant fibrosis, while someone with ALT >1000 U/L from acute hepatitis A will fully recover.
Normal ALT does NOT exclude significant liver disease 5. Current upper limits of normal may be too high; some suggest ALT >30 U/L (males) or >19 U/L (females) warrants investigation 5.
Do not simply repeat labs and wait - this delays diagnosis of treatable conditions like hepatitis C, hemochromatosis, or progressive NAFLD 5.
AST >500 U/L or ALT >200 U/L would be uncommon for alcoholic hepatitis (except with acetaminophen co-ingestion) and should prompt consideration of other causes 1.
Bottom Line
Your normal GGT with elevated transaminases and AST/ALT <1 most strongly suggests NAFLD as the primary diagnosis, assuming metabolic risk factors are present. However, viral hepatitis and medication effects must be systematically excluded through serologic testing and medication review before attributing this solely to fatty liver disease. Proceed with ultrasound imaging and the laboratory workup outlined above rather than simply repeating liver enzymes.